Polydopamine‐mediated polypyrrole/doxorubicin nanocomplex for chemotherapy‐enhanced photothermal therapy in both NIR‐I and NIR‐II biowindows against tumor cells

Abstract Photothermal therapy (PTT) is featured by the desirable spatiotemporal controllability and excellent specificity, which has been identified as one of the important tumor treatment methods. Although promising, the efficacy of PTT is still limited and needs further improvement. In this work, a kind of PPy‐PDA‐PEG@DOX nanocomplex was designed and constructed for chemotherapy‐enhanced PTT in both near‐infrared (NIR)‐I and NIR‐II biowindows against tumor cells, which was integrated by the polypyrrole (PPy) core, polydopamine (PDA) shell, polyethylene glycol (PEG) linkage, and doxorubicin (DOX) payload. This constructed PPy‐PDA‐PEG@DOX nanocomplex was uniform in size around 56.3 nm, and with the optimized DOX loading content at 37.4%. The photothermal conversion efficiencies of this nanocomplex were calculated to be around 23.1 and 30.8% in NIR‐I and NIR‐II biowindows, respectively, showing good photothermal capacity and stability. The loaded DOX could be released in stimuli‐responsive manners. The therapeutic efficacy was enhanced by PPy‐PDA‐PEG@DOX nanocomplex, indicating the high effectiveness of chemotherapy‐enhanced phototherapy. This developed PPy‐PDA‐PEG@DOX nanocomplex shows promising applications in tumor treatment applications.